Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been assigned a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $31.1333.

A number of equities research analysts recently weighed in on PRVA shares. Stephens reaffirmed an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, December 4th. Canaccord Genuity Group increased their price target on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Barclays raised their price target on shares of Privia Health Group from $23.00 to $25.00 and gave the company an “equal weight” rating in a report on Wednesday, March 25th. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price objective on shares of Privia Health Group in a research report on Thursday, February 26th. Finally, Truist Financial boosted their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd.

Privia Health Group Stock Up 0.7%

Privia Health Group stock opened at $21.21 on Friday. The business has a fifty day moving average of $22.20 and a two-hundred day moving average of $23.42. The firm has a market cap of $2.62 billion, a P/E ratio of 124.76, a P/E/G ratio of 1.31 and a beta of 0.87. Privia Health Group has a twelve month low of $18.77 and a twelve month high of $26.51.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million for the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The business’s revenue was up 17.4% compared to the same quarter last year. During the same period last year, the business posted $0.21 EPS. Equities analysts expect that Privia Health Group will post 0.14 earnings per share for the current year.

Insiders Place Their Bets

In other Privia Health Group news, CFO David Mountcastle sold 7,697 shares of Privia Health Group stock in a transaction on Friday, February 27th. The shares were sold at an average price of $25.05, for a total value of $192,809.85. Following the transaction, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,331,370.45. The trade was a 4.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Matthew Shawn Morris sold 16,550 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $25.00, for a total value of $413,750.00. Following the transaction, the director directly owned 68,188 shares in the company, valued at approximately $1,704,700. The trade was a 19.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 242,191 shares of company stock valued at $5,520,587. 10.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Privia Health Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its holdings in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after acquiring an additional 95,371 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Privia Health Group by 24.7% during the first quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock valued at $916,000 after acquiring an additional 8,068 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Privia Health Group by 3.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after purchasing an additional 3,714 shares during the last quarter. Intech Investment Management LLC raised its position in shares of Privia Health Group by 55.1% in the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after purchasing an additional 20,082 shares during the last quarter. Finally, Acadian Asset Management LLC acquired a new stake in Privia Health Group in the 1st quarter worth approximately $154,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.